Showing results (491-500 of 504) with videos related to
Sort By:
Pageof 51
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal GammopathiesLeire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, et al.Blood|July 22, 2020
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myelomaIbai Goicoechea, Noemi Puig, Maria-Teresa Cedena, et al.The Journal of Allergy and Clinical Immunology|November 1, 2025
Immunologic biomarkers of noninfectious complications and overall survival in common variable immunodeficiencyAlba Torres-Valle, Jana Neirinck, Susana L Silva, et al.Blood|January 29, 2026
Immune biomarkers of increased infection risk in multiple myelomaAintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos, et al.Blood|November 5, 2020
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemiaJosep-Maria Ribera, Mireia Morgades, Juana Ciudad, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2021
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug RegistrationKenneth C Anderson, Daniel Auclair, Stacey J Adam, et al.The Lancet. Haematology|February 6, 2026
Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trialValentín Ortiz-Maldonado, Núria Martínez-Cibrian, Leticia Alserawan, et al.Leukemia & Lymphoma|August 25, 2012
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working GroupArjan A van de Loosdrecht, Robin Ireland, Wolfgang Kern, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple MyelomaRosalinda Termini, David Žihala, Evangelos Terpos, et al.Blood|May 4, 2026
Genetics and MRD for therapy allocation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemiaJosep-Maria Ribera, Anna Torrent, Mireia Morgades, et al.Pageof 51